A simple blood test ratio called CLR (C-reactive protein-to-lymphocyte ratio) significantly predicts stroke risk and survival outcomes, according to research reviewed by Gram Research. In a study of 23,483 Americans, each unit increase in CLR raised stroke odds by 0.5%, and stroke patients with elevated CLR had substantially worse survival rates. Because CLR is calculated from routine blood tests doctors already perform, it could become a practical tool for identifying high-risk patients without additional testing.
Researchers analyzed data from nearly 24,000 Americans to test whether a simple blood measurement called the C-reactive protein-to-lymphocyte ratio (CLR) could predict stroke risk. According to Gram Research analysis, people with higher CLR levels were significantly more likely to have had a stroke, and stroke patients with elevated CLR had worse survival outcomes. The CLR measurement is easy to calculate from routine blood tests already done at doctor visits, making it potentially useful for identifying people at higher risk who need closer monitoring or early treatment.
Key Statistics
A 2026 analysis of 23,483 Americans from the National Health and Nutrition Examination Survey found that elevated C-reactive protein-to-lymphocyte ratio (CLR) was significantly associated with higher odds of stroke prevalence, with each unit increase raising stroke odds by 0.5%.
Among 789 stroke patients in the study, those with CLR above the optimal threshold demonstrated significantly higher all-cause mortality rates compared to those with lower CLR levels, as shown by Kaplan-Meier survival analysis.
Receiver operating characteristic analysis demonstrated that CLR exhibited superior predictive ability for stroke compared to established inflammation markers including the Systemic Immune-Inflammation Index, Neutrophil-to-Lymphocyte Ratio, and C-reactive protein alone.
The Quick Take
- What they studied: Whether a simple blood test ratio (comparing inflammation markers) could predict who has had a stroke and who might not survive as long after a stroke
- Who participated: 23,483 Americans from the National Health and Nutrition Examination Survey between 1999 and 2010, including 789 people with a history of stroke
- Key finding: People with higher CLR levels had significantly higher odds of having had a stroke. Among stroke patients, those with elevated CLR had worse survival rates over time.
- What it means for you: If your doctor finds a high CLR on your blood work, it might mean you need extra attention to stroke prevention. However, this is one test among many factors doctors consider—it’s not a diagnosis by itself.
The Research Details
Researchers looked at health information collected from thousands of Americans over 12 years. They examined blood test results and medical histories to see if people with higher CLR measurements were more likely to have had strokes. For people who had already experienced a stroke, they tracked how long they survived and whether CLR predicted their outcomes.
The CLR is calculated by taking a person’s C-reactive protein level (a marker of inflammation in the body) and dividing it by their lymphocyte count (a type of white blood cell). The researchers used statistical methods to account for other factors that affect stroke risk, like age, smoking, and diabetes, to isolate CLR’s independent effect.
They also compared CLR to other inflammation-related blood measurements to see which one was the best predictor of stroke.
This approach is important because it uses information doctors already collect during routine blood tests. If CLR proves reliable, doctors wouldn’t need expensive new tests—they could simply calculate this ratio from existing lab work to identify high-risk patients earlier.
This study analyzed a large, nationally representative sample of Americans, which makes the findings more likely to apply to the general population. The researchers carefully adjusted for other factors that influence stroke risk. However, because this is a cross-sectional study analyzing existing data rather than following people forward in time, it shows association but not definitive cause-and-effect. The study was conducted between 1999-2010, so some findings may not reflect current medical practices.
What the Results Show
The main finding was clear: for every unit increase in CLR, the odds of having had a stroke increased by about 0.5% (OR = 1.005). While this sounds small, across many people it adds up to a meaningful difference in stroke risk.
Among the 789 people who had experienced a stroke, those with higher CLR measurements had significantly worse survival rates. The researchers created survival curves showing that stroke patients with CLR above a certain threshold died at higher rates than those with lower CLR.
When the researchers compared CLR to other inflammation markers commonly used in medicine (like the neutrophil-to-lymphocyte ratio and C-reactive protein alone), CLR was better at predicting both stroke presence and survival outcomes. This suggests CLR captures something important about stroke risk that other single measurements miss.
The relationship between CLR and mortality risk appeared to be straightforward—higher CLR meant worse outcomes—without any unexpected patterns. This consistency is reassuring because it suggests the relationship is reliable and not due to chance.
Previous research has shown that inflammation plays a role in stroke development and recovery. This study builds on that knowledge by showing that CLR, which combines two inflammation-related measurements, may be better than looking at either measurement alone. The finding that CLR outperforms established markers suggests researchers should continue exploring combination measurements rather than relying on single blood tests.
This study analyzed data collected over a decade ago, so current stroke treatments and prevention strategies may have changed. The study design captured a snapshot in time rather than following people forward, which limits our ability to prove CLR actually causes worse outcomes. The researchers couldn’t account for all possible factors affecting stroke risk, such as diet or exercise habits. Additionally, the study was conducted in the U.S., so results may not apply equally to other populations around the world.
The Bottom Line
If your blood work shows an elevated CLR, discuss with your doctor whether you need additional stroke prevention measures. This might include blood pressure management, cholesterol control, or lifestyle changes. CLR should be considered alongside other stroke risk factors, not as a standalone indicator. (Moderate confidence—based on observational data, not clinical trials)
People with risk factors for stroke (high blood pressure, diabetes, smoking history) should be aware of this marker. Doctors may find it useful for identifying patients who need closer monitoring. People without stroke risk factors probably don’t need to specifically request CLR testing, as their overall risk is lower.
If you make lifestyle changes based on a high CLR result, you might see improvements in inflammation markers within weeks to months. However, stroke prevention is a long-term commitment—benefits typically appear over years of consistent healthy habits.
Frequently Asked Questions
What is CLR and why does it matter for stroke risk?
CLR (C-reactive protein-to-lymphocyte ratio) combines two blood measurements to assess inflammation. Research shows it predicts stroke risk better than measuring either marker alone. Doctors can calculate it from routine blood tests without additional expense or testing.
If my CLR is high, does that mean I will have a stroke?
A high CLR increases your stroke risk but doesn’t guarantee you’ll have one. Many factors influence stroke risk, including blood pressure, cholesterol, smoking, and diabetes. Discuss your individual risk with your doctor rather than relying on CLR alone.
How often should I get my CLR checked?
Most people benefit from annual blood work that includes the measurements needed to calculate CLR. If you have stroke risk factors or a history of stroke, your doctor may recommend more frequent testing to monitor your inflammation levels.
Can I lower my CLR to reduce stroke risk?
Yes. Lifestyle changes that reduce inflammation—including regular exercise, a heart-healthy diet, weight loss, stress management, and quitting smoking—can lower CLR. Some medications also reduce inflammation markers. Work with your doctor on a personalized prevention plan.
Is CLR better than other stroke risk tests?
This study found CLR outperformed other single inflammation markers at predicting stroke. However, doctors typically use multiple tests and risk factors together. CLR is valuable as one tool among many, not as a replacement for comprehensive stroke risk assessment.
Want to Apply This Research?
- Log your CLR value when you receive blood work results, then track it alongside other inflammation markers (CRP, neutrophil-to-lymphocyte ratio) every 6-12 months to monitor trends over time
- Set reminders for annual blood work to monitor CLR levels, and use the app to track lifestyle factors that reduce inflammation: daily steps, servings of vegetables, sleep hours, and stress management activities
- Create a dashboard showing your CLR trend over time alongside your blood pressure, cholesterol, and weight. Set alerts if CLR rises above your personal baseline to prompt conversations with your doctor about prevention strategies
This research presents observational findings from a secondary analysis of existing data and should not be interpreted as medical advice. A high CLR does not diagnose stroke risk or guarantee future stroke. Individual stroke risk depends on many factors including age, blood pressure, cholesterol, smoking status, diabetes, and family history. Consult with your healthcare provider about your personal stroke risk, appropriate screening, and prevention strategies. This article is for educational purposes and does not replace professional medical evaluation or treatment recommendations.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.